EUVIMEDEUVIMED entdecken
Open Access

Senolysis Enabled by Senescent Cell‐Sensitive Bioorthogonal Tetrazine Ligation

Mengyang Chang, Yue Dong, Hang Xu, Alexis B Cruickshank-Taylor, Jacob S Kozora, Baran Behpour, Wei Wang iD

Angewandte Chemie International Edition · 2024

DOI: 10.1002/anie.202315425 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2024. Verfasst von Mengyang Chang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona, 85721, USA. Hauptthemen laut MEDLINE: Heterocyclic Compounds, Prodrugs. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences, University of Arizona.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although the clearance of senescent cells has been proven to slow down the aging process and promote anti‐cancer chemotherapy, the development of senolytics remains challenging. Herein, we report a senolytic strategy enabled by senescent cell‐sensitive bioorthogonal tetrazine ligation. Our design is based on linking dihydrotetrazine (Tz) to a galactose (Gal) moiety that serves both as a recognition moiety for senescence‐associated β‐galactosidase and a caging group for the control of tetrazine activity. Gal‐Tz enables efficient click‐release of a fluorescent hemicyanine and doxorubicin from a trans ‐cyclooctene‐caged prodrug to detect and eliminate senescent HeLa and A549 cells over non‐senescent counterparts with a 16.44 senolytic index. Furthermore, we leverage the strategy for the selective activation and delivery of proteolysis‐targeting chimeras (PROTACs) as senolytics. PROTAC prodrug TCO‐ARV‐771 can be selectively activated by Gal‐Tz and delivered into senescent HeLa and A549 cells to induce the degradation of bromodomain‐containing protein 4. Senolytic PROTACs may offer an efficient way for intervention on cell senescence thanks to their unique capacity to degrade target proteins in a sub‐stoichiometric and catalytic fashion. The results of this study establish the bioorthogonal tetrazine ligation approach as a viable strategy for selective removal of senescent cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heterocyclic CompoundsProdrugsHumansCell Line, TumorSenotherapeuticsCellular Senescence

Stichwörter der Autor:innen

Bioorthogonal chemistryProdrugSenescenceSenolyticsTetrazine click-release

Substanzen

SenotherapeuticsHeterocyclic CompoundsProdrugs

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, University of Arizona, Tucson, Arizona, 85721, USA.
  • Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona, 85721, USA.
  • Departments of Pharmacology and Toxicology and Chemistry and Biochemistry, University of Arizona Cancer Center, and BIO5 Institute, University of Arizona, Tucson, Arizona, 85721, USA.

ORCID-Profile: Wei Wang

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences
  • University of Arizona

Zitieren

APA

Chang, M., Dong, Y., Xu, H., Cruickshank-Taylor, A. B., Kozora, J. S., Behpour, B., & Wang, W. (2024). Senolysis Enabled by Senescent Cell‐Sensitive Bioorthogonal Tetrazine Ligation. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202315425

Vancouver

Chang M, Dong Y, Xu H, Cruickshank-Taylor AB, Kozora JS, Behpour B, et al. Senolysis Enabled by Senescent Cell‐Sensitive Bioorthogonal Tetrazine Ligation. Angewandte Chemie International Edition. 2024. doi:10.1002/anie.202315425

BibTeX
@article{Chang2024,
  author = {Chang, Mengyang and Dong, Yue and Xu, Hang and Cruickshank-Taylor, Alexis B and Kozora, Jacob S and Behpour, Baran and Wang, Wei},
  title = {Senolysis Enabled by Senescent Cell‐Sensitive Bioorthogonal Tetrazine Ligation},
  journal = {Angewandte Chemie International Edition},
  year = {2024},
  doi = {10.1002/anie.202315425}
}
Kostenlos starten →